When was Sorbent Therapeutics founded?

Sorbent Therapeutics was founded in 2005 and raised its 1st funding round 5 years after it was founded.

Where is Sorbent Therapeutics located?

Sorbent Therapeutics is headquartered in Sunnyvale, United States.

Who is the current CEO of Sorbent Therapeutics?

Don Joseph of Sorbent Therapeutics. They have also founded 1 company.

How many employees does Sorbent Therapeutics have?

As of Jul 01, 2024, the latest employee count at Sorbent Therapeutics is 1 - 10.

Is Sorbent Therapeutics a funded company?

Sorbent Therapeutics is a funded company, having raised a total of $90.9M across 6 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Sep 13, 2010.

When was the latest funding round of Sorbent Therapeutics?

Sorbent Therapeutics' latest funding was a $***** Series D round on May 13, 2014, with participation from 3 investors. Its primary sector is Beauty & Personal Care Products. In United States, the Beauty & Personal Care Products sector has seen $227M in funding in 2026 to date.

Where does Sorbent Therapeutics rank among its competitors?

Sorbent Therapeutics ranks 181st amongst 1513 active competitors, of which 73 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Glossier, which secured $45M in Jun, 2026.

Who are the top competitors of Sorbent Therapeutics?

Sorbent Therapeutics' top competitors include Procter & Gamble, Douglas and L'Occitane. Among them, Glossier secured the most recent funding round in June, 2026.

Sorbent Therapeutics - 2026 Company Profile, Team, Funding & Competitors

Sorbent Therapeutics is a deadpooled company based in Sunnyvale (United States), founded in 2005 by Don Joseph. It operates as a Trusted Australian brand providing soft, strong, and sustainable tissue products. Sorbent Therapeutics has raised $90.9M in funding from investors like Novartis, Sofinnova Investments and CMEA Capital. The company has 1513 active competitors, including 73 funded and 144 that have exited. Its top competitors include companies like Procter & Gamble, Douglas and L'Occitane.

Company Details

Trusted Australian brand providing soft, strong, and sustainable tissue products. This company has been serving Australians for over 70 years, offering a wide range of tissue products, including toilet rolls, facial tissues, and flushable wipes. The company is committed to providing quality products that are gentle on the skin and kind to the environment. They focus on product innovation to meet customer needs, constantly improving the softness and thickness of their tissue rolls. The company aims to provide comfort and reliability, ensuring a fresh and clean experience. They are dedicated to sustainability, reducing their environmental footprint while maintaining the softness and strength customers love. The company values customer relationships and strives to be there for Australians through thick and thin.

Key Metrics

Founded Year

2005

Location

Sunnyvale, United States

Stage

Deadpooled

Total Funding

$90.9M in 6 rounds

Latest Funding Round

Series D, May 13, 2014, $*****

Investors

Novartis & 5 more

Ranked

181^st among 1513 active competitors

Employee Count

1 - 10 as on Jul 01, 2024

Similar Companies

Akebia Therapeutics & 125 more

View Sorbent Therapeutics' full profile

Sorbent Therapeutics has raised a total funding of $90.9M over 6 rounds. Its first funding round was on Sep 13, 2010. Its latest funding round was a Series D round on May 13, 2014 for $*****. 3 investors participated in its latest round. Sorbent Therapeutics has 6 institutional investors.

Here is the list of recent funding rounds of Sorbent Therapeutics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 13, 2014	2530614	Series D	7448860	4375721	3152057	7868911
Apr 01, 2013	8158122	Series C	3997832	8120718	1130627	Arch Venture Partners & 1 more
Aug 07, 2012	4079143	Series C	7591442	5396929	9574324	Arch Venture Partners & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Sorbent Therapeutics's funding rounds and investors

The founders of Sorbent Therapeutics is Don Joseph. Don Joseph is the CEO of Sorbent Therapeutics.

Here are the details of Sorbent Therapeutics' key team members:

Don Joseph: CEO of Sorbent Therapeutics.

View details of Sorbent Therapeutics's Founder profiles and Board Members

Sorbent Therapeutics' employee count trend

Sorbent Therapeutics has 1 - 10 employees as of Jul 24. Here is Sorbent Therapeutics's employee count trend over the years:

Employee count trend for Sorbent Therapeutics

Uncover Sorbent Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sorbent Therapeutics include Procter & Gamble, Douglas and L'Occitane. Here is the list of Top 10 competitors of Sorbent Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Procter & Gamble 1837, Cincinnati (United States), Public	Provider of FMCG conglomerate products	-	Alcor Fund, Black Capital Investments & 5 others	79/100
2nd	Douglas 1910, Dusseldorf (Germany), Public	Retailer offering wide array of perfumes	$259M	AlpInvest Partners, EVCP & 3 others	73/100
3rd	L'Occitane 1976, Paris (France), Public	Beauty and personal care brand	$10M	Capital Resource Partners, Shinettis	72/100
4th	L'Oreal 1909, Clichy (France), Public	Internet first brand of skin & hair care, and makeup products for men and women	-	Independents United, Nestle & 3 others	70/100
5th	Glossier 2005, New York City (United States), Series E	Internet first brand offering multicategory beauty products	$266M	IVP, Lone Pine Capital & 23 others	69/100
6th	E.L.F Cosmetics 2004, Oakland (United States), Public	Internet first brand offering multi category color cosmetics	-	TSG Consumer Partners, FS Investors	66/100
7th	Akebia Therapeutics 2007, Cincinnati (United States), Public	Developing therapeutics solutions to treat patients with kidney disease	$91M	Genechem, Longitude Capital & 13 others	66/100
8th	Aurinia Pharmaceuticals 1993, Edmonton (Canada), Public	Developer of therapeutics for autoimmune diseases	-	RA Capital Management, VenBio & 10 others	64/100
9th	Sugar Cosmetics 2012, Mumbai (India), Series D	Platform offering cosmetic and personal care products	$96.3M	India Quotient, A91 Partners & 71 others	62/100
10th	Too Faced 1998, Orange (United States), Acquired	Brand offering makeup products	$71.4M	Weston Presidio, Main Post Partners	61/100
181st	Sorbent Therapeutics 2005, Sunnyvale (United States), Deadpooled	Trusted Australian brand providing soft, strong, and sustainable tissue products	$90.9M	Novartis, Arch Venture Partners & 4 others	33/100